Clinical evidence of high-power 675 nm laser system equipped with a faster treatment modality for the management of pigmented lesions and skin rejuvenation [0.03%]
高功率675nm激光系统治疗色素病变和皮肤年轻化的临床证据
Massimo D F Vitale,Francesca Madeddu,Irene Fusco et al.
Massimo D F Vitale et al.
Case Reports
JAAD case reports. 2025 Feb 4:58:93-98. DOI:10.1016/j.jdcr.2025.01.013 2025
Adjuvant use of topical metformin with standard therapies in recalcitrant central centrifugal cicatricial alopecia: A case series [0.03%]
外用二甲双胍联合标准疗法治疗顽固性中央离心性瘢痕性脱发的辅助治疗：病例系列报告
Monica N Williams,Janeth R Campbell,Sach Thakker et al.
Monica N Williams et al.
Case Reports
JAAD case reports. 2025 Jan 4:57:74-77. DOI:10.1016/j.jdcr.2024.12.025 2025
Relapsing localized pagetoid reticulosis despite radiation therapy [0.03%]
尽管进行了放射治疗，局灶性Paget样网状细胞增生症还是复发了
Sara Suhl,Tessa M LeWitt,Alexander Kaminsky et al.
Sara Suhl et al.
Case Reports
JAAD case reports. 2025 Feb 4:58:77-81. DOI:10.1016/j.jdcr.2025.01.010 2025
Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting [0.03%]
住院患者在接受enfortumab vedotin和pembrolizumab治疗时皮肤不良反应的识别与管理
Emma L Myers,Jessica Liu,Sabrina M Shearer et al.
Emma L Myers et al.
Case Reports
JAAD case reports. 2025 Jan 28:58:85-92. DOI:10.1016/j.jdcr.2024.12.037 2025
Jane Hong,Sherman Chu,Mary Cowden et al.
Jane Hong et al.
Atypical bullous systemic lupus erythematosus with features of linear IgA bullous dermatosis [0.03%]
非典型的具有线性IgA大疱性皮肤病特征的系统性红斑狼疮水疱病
Roy Jiang,Amanda G Zhou,Christine J Ko et al.
Roy Jiang et al.
Case Reports
JAAD case reports. 2025 Feb 7:58:74-76. DOI:10.1016/j.jdcr.2024.12.040 2025
Response to Fässler et al's "Successful treatment of refractory folliculitis decalvans with apremilast" [0.03%]
对Fässler等的《Apremilast成功治疗难治性脱发性毛囊炎》的回应
Charlotte Dethier,Sara Azirar,Lina Verluyten et al.
Charlotte Dethier et al.
Vixey Silva,Bret-Ashleigh Coleman,Heather Kopecky et al.
Vixey Silva et al.
Response to Dethier et al, "Experience in nine additional cases of apremilast for therapy-resistant folliculitis decalvans" [0.03%]
对Dethier等关于《九例难治性秃发性毛囊炎使用阿普米司特治疗的额外病例报告》的回复
Pierre A de Viragh,Seyed Morteza Seyed Jafari
Pierre A de Viragh
Atypical presentation of TRPV3 variant: Cerebral palsy and intellectual disability without dermatologic features of olmsted syndrome [0.03%]
不典型TRPV3变异表现：无Olms ted综合征皮肤病变特征的脑瘫及智力障碍
Mohamed Adil Shah Khoodoruth,Widaad Nuzhah Chut-Kai Khoodoruth,Yasser Saeed Khan
Mohamed Adil Shah Khoodoruth